John Y. Caloz
2017
In 2017, John Y. Caloz earned a total compensation of $577K as Chief Financial Officer and Treasurer at CytRx.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $77,000 |
| Salary | $400,000 |
| Total | $577,000 |
Caloz received $400K in salary, accounting for 69% of the total pay in 2017.
Caloz also received $100K in bonus and $77K in option awards.
Rankings
In 2017, John Y. Caloz's compensation ranked 11,343rd out of 14,666 executives tracked by ExecPay. In other words, Caloz earned more than 22.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,343 out of 14,666 | 23rd |
Division Manufacturing | 4,447 out of 5,772 | 23rd |
Major group Chemicals And Allied Products | 1,618 out of 2,075 | 22nd |
Industry group Drugs | 1,335 out of 1,731 | 23rd |
Industry Biological Products, Except Diagnostic Substances | 237 out of 313 | 24th |
Source: SEC filing on June 26, 2019.
Caloz's colleagues
We found two more compensation records of executives who worked with John Y. Caloz at CytRx in 2017.
News
CytRx CEO Stephen Snowdy's 2023 pay slips 3% to $545K
August 20, 2024
CytRx CEO Stephen Snowdy receives $563K in 2022
July 28, 2023
CytRx CEO Steven Kriegsman's 2021 pay jumps 592% to $7M
June 16, 2022
CytRx CEO Steven Kriegsman's 2020 pay falls 41% to $1M
June 14, 2021
CytRx CEO Steven Kriegsman's 2019 pay jumps 68% to $1.7M
June 12, 2020
CytRx CEO Steven Kriegsman's 2018 pay falls 48% to $1M
June 26, 2019